Caley Castelein is a healthcare-focused investor who leads Kearny Venture Partners. See contact routes.
Caley Castelein is a healthcare-focused investor who leads Kearny Venture Partners, investing in early- to late-stage drug and healthcare companies with initial checks of $2–$8 million and total lifetime investments of $10–$15 million per portfolio company. His firm targets sectors including biotechnology, medical devices, and health care, with a thesis centered on developing novel therapies to replace existing products and address unmet medical needs. Notable portfolio companies include PROCEPT BioRobotics, Aerpio Pharmaceuticals, Qool Therapeutics, and ViewRay, while Castelein has also served on the boards of AliveCor, Tourmaline Bio, and NewBridge Pharmaceuticals.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.
Investors like Caley Castelein · Full investor directory · Investor access · Company funding database